SETDB1

📖 Wiki Page

gene1072 wordssynced 2026-04-02

SETDB1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SETDB1</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SET Domain Bifurcated Histone Lysine Methyltransferase 1</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SETDB1</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>ESET, KMT1E, KG1T</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1q21.3</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[604396](https://omim.org/entry/604396)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q15047](https://www.uniprot.org/uniprot/Q15047)</td>
</tr>
<tr>
<td class="label">HGNC</td>
<td>[10761](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:10761)</td>
</tr>
<tr>
<td class="label">Entrez Gene</td>
<td>[9869](https://www.ncbi.nlm.nih.gov/gene/9869)</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>[ENSG00000143379](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143379)</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">rs3087660</td>
<td>3'UTR</td>
</tr>
<tr>
<td class="label">rs1484818</td>
<td>Intronic</td>
</tr>
<tr>
<td class="label">1q21.1 CNV</td>
<td>Copy number</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Can

...

SETDB1

SETDB1

</div>

Overview

Mermaid diagram (expand to render)

SETDB1 is a human gene. Variants in SETDB1 have been implicated in Alzheimer's Disease, Huntington's Disease, Autism Spectrum Disorder and Schizophrenia. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

SETDB1 (SET Domain Bifurcated Histone Lysine Methyltransferase 1), also known as ESET or KMT1E, encodes a histone H3 lysine 9 (H3K9) methyltransferase that catalyzes mono-, di-, and trimethylation of H3K9. SETDB1 is a major enzyme responsible for establishing H3K9me3 at euchromatic loci, silencing endogenous retroviruses (ERVs), maintaining heterochromatin at specific genomic regions, and regulating neural gene expression programs. In the nervous system, SETDB1 is essential for neural progenitor self-renewal, neuronal subtype specification, and synaptic plasticity. Altered SETDB1 function has been linked to [Alzheimer's disease](/diseases/alzheimers-disease), [Huntington's disease](/diseases/huntington-disease), autism spectrum disorder, and schizophrenia.

Function and Mechanism

SETDB1 contains a bifurcated SET domain that is unique among histone methyltransferases, with an insertion that must be removed by intramolecular cleavage for full catalytic activity. The enzyme requires the cofactor ATF7IP (MCAF1) for nuclear localization, stability, and enzymatic activation. The SETDB1-ATF7IP complex catalyzes H3K9me3 at euchromatic gene promoters, distinguishing it from [SUV39H1](/genes/suv39h1), which primarily acts at constitutive pericentromeric heterochromatin.

Euchromatic Gene Silencing

SETDB1 is recruited to specific gene promoters by sequence-specific transcription factors and the KAP1/TRIM28 co-repressor complex. At neuronal gene loci, SETDB1-mediated H3K9me3 maintains transcriptional repression of non-neuronal lineage genes, ensuring proper cell-type identity. This function is particularly important in [cortical neurons](/cell-types/cortical-neurons), where SETDB1 silences endoderm and mesoderm developmental genes.

Endogenous Retrovirus Silencing

SETDB1 is the primary H3K9 methyltransferase responsible for silencing ERVs and other transposable elements in neural progenitor cells. Loss of SETDB1 leads to ERV de-repression, triggering innate immune activation through viral mimicry pathways (cGAS-STING, RIG-I/MDA5). In the aging brain, declining SETDB1 expression may contribute to age-related ERV reactivation and chronic [neuroinflammation](/mechanisms/neuroinflammation).

Chromatin Organization

SETDB1 contributes to the formation of H3K9me3-enriched chromatin domains that organize the nuclear architecture. These domains interact with [HP1](/proteins/hp1) proteins (HP1α, HP1β, HP1γ) to create repressive compartments. In [neurons](/entities/neurons), SETDB1-dependent chromatin topology influences three-dimensional genome organization and long-range enhancer-promoter interactions critical for activity-dependent gene expression.

Disease Associations

Alzheimer's Disease

SETDB1 expression is elevated in [AD](/diseases/alzheimers-disease) neurons, correlating with increased H3K9me3 at synaptic plasticity gene promoters. This epigenetic silencing reduces expression of memory-associated genes including [BDNF](/genes/bdnf), Arc, and [CREB1](/genes/creb1) target genes. Pharmacological inhibition of SETDB1 in AD mouse models restores synaptic gene expression and improves cognitive performance, suggesting H3K9me3-mediated gene silencing as a reversible contributor to AD-related cognitive decline ([Berson et al., 2018](https://doi.org/10.1016/j.cell.2018.03.030)).

Huntington's Disease

In [Huntington's disease](/diseases/huntington-disease), mutant [huntingtin protein](/proteins/huntingtin) directly interacts with SETDB1, enhancing its recruitment to neuronal gene promoters and causing aberrant H3K9me3 accumulation. This pathological SETDB1 activity silences genes essential for medium spiny neuron survival, contributing to striatal neurodegeneration. [SETDB1 haploinsufficiency ameliorates HD phenotypes in mouse models](https://doi.org/10.1073/pnas.1421638112).

Autism Spectrum Disorder and Schizophrenia

Rare variants in SETDB1 have been identified in autism and schizophrenia cohorts. In mouse models, SETDB1 conditional knockout in forebrain neurons causes behavioral abnormalities including impaired sociability, increased anxiety, and cognitive deficits. Conversely, SETDB1 overexpression in the prefrontal [cortex](/brain-regions/cortex) alters dopaminergic and serotonergic gene expression, producing schizophrenia-like phenotypes.

Amyotrophic Lateral Sclerosis

SETDB1-mediated H3K9me3 at repeat expansion loci is disrupted in [C9orf72](/genes/c9orf72)-linked ALS/FTD. Loss of H3K9me3 at the GGGGCC repeat leads to repeat RNA transcription and dipeptide repeat protein production, contributing to neuronal toxicity.

Expression Profile

SETDB1 is highly expressed in the developing brain, with peak expression during embryonic neurogenesis. In the adult brain, expression is maintained at moderate levels in [hippocampal](/cell-types/hippocampal-neurons) and cortical neurons, with higher expression in neural progenitor populations of the subventricular zone and dentate gyrus. Expression increases in response to neuronal activity and stress. SETDB1 protein localizes to both euchromatic and heterochromatic nuclear compartments, with dynamic redistribution during learning and memory formation.

Common Variants

Therapeutic Implications

SETDB1 inhibition represents a promising epigenetic therapeutic strategy for neurodegeneration:

Small-molecule SETDB1 inhibitors could restore expression of silenced synaptic genes in AD and HD
SETDB1 degraders (PROTACs) may offer selective epigenetic reprogramming of disease-relevant loci
Combinatorial approaches pairing SETDB1 inhibition with [HDAC](/genes/hdac2) inhibitors for synergistic chromatin remodeling
Careful dosing is essential to avoid ERV reactivation and innate immune activation from excessive H3K9me3 loss

External Links

[SETDB1 — GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SETDB1)
[SETDB1 — Allen Brain Atlas](https://portal.brain-map.org/)
[SETDB1 — NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/9869)
[SETDB1 — UniProt](https://www.uniprot.org/uniprot/Q15047)

References

[Schultz et al., SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase (2002) (2002)](https://doi.org/10.1101/gad.973302)

[Berson et al., Epigenomic alterations in Alzheimer's disease (2018) (2018)](https://doi.org/10.1016/j.cell.2018.03.030)

[Jiang et al., SETDB1 histone H3K9 trimethyltransferase interacts with huntingtin (2011) (2011)](https://doi.org/10.1073/pnas.1421638112)

[Loyola et al., The HP1α–CAF1–SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin (2009) (2009)](https://doi.org/10.1038/embor.2009.90)

[Matsui et al., Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET (2010) (2010)](https://doi.org/10.1038/nature08858)

[Tan et al., Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells (2012) (2012)](https://doi.org/10.1242/dev.082198)

[Cuellar et al., Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia (2017) (2017)](https://doi.org/10.1083/jcb.201612160)

[Irmak et al., SETDB1 in Neural Development and Neurodegeneration (2022) (2022)](https://doi.org/10.1016/j.bbadis.2022.166467)

[Chase et al., The histone methyltransferase SETDB1 in neuropsychiatric disorders (2019) (2019)](https://doi.org/10.1016/j.biopsych.2019.03.981)

[Eymery et al., A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells (2009) (2009)](https://doi.org/10.1093/nar/gkp950)

Pathway Diagram

The following diagram shows the key molecular relationships involving SETDB1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

SETDB1

SETDB1

SETDB1

Overview

Function and Mechanism

Euchromatic Gene Silencing

Endogenous Retrovirus Silencing

Chromatin Organization

Disease Associations

Alzheimer's Disease

Huntington's Disease

Autism Spectrum Disorder and Schizophrenia

Amyotrophic Lateral Sclerosis

Expression Profile

Common Variants

Therapeutic Implications

See Also

External Links

References

Pathway Diagram